These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 19218166)
21. Alteration of PDGFRβ-Akt-mTOR pathway signaling in fibrosarcomatous transformation of dermatofibrosarcoma protuberans. Hiraki-Hotokebuchi Y; Yamada Y; Kohashi K; Yamamoto H; Endo M; Setsu N; Yuki K; Ito T; Iwamoto Y; Furue M; Oda Y Hum Pathol; 2017 Sep; 67():60-68. PubMed ID: 28711648 [TBL] [Abstract][Full Text] [Related]
22. PRAME expression in fibrosarcomatous dermatofibrosarcoma protuberans. Ichiki T; Ito T; Shiraishi S; Nakashima Y; Nakahara T; Oda Y Sci Rep; 2024 Oct; 14(1):22973. PubMed ID: 39362949 [TBL] [Abstract][Full Text] [Related]
23. Perianal dermatofibrosarcoma protuberans: a case report. Mc Cormack O; Heaslip IS; Abdulrahim M; Murphy MN; Schranz M; O'Mahony JB Cutis; 2011 Feb; 87(2):85-8. PubMed ID: 21416775 [TBL] [Abstract][Full Text] [Related]
24. Dermatofibrosarcoma protuberans with fibrosarcomatous areas: a clinico-pathologic and immunohistochemic study in four cases. Díaz-Cascajo C; Weyers W; Borrego L; Iñarrea JB; Borghi S Am J Dermatopathol; 1997 Dec; 19(6):562-7. PubMed ID: 9415611 [TBL] [Abstract][Full Text] [Related]
25. Sarcomas arising in dermatofibrosarcoma protuberans: a reappraisal of biologic behavior in eighteen cases treated by wide local excision with extended clinical follow up. Goldblum JR; Reith JD; Weiss SW Am J Surg Pathol; 2000 Aug; 24(8):1125-30. PubMed ID: 10935653 [TBL] [Abstract][Full Text] [Related]
26. A clinicopathologic review of a case series of dermatofibrosarcoma protuberans with fibrosarcomatous differentiation. Kuzel P; Mahmood MN; Metelitsa AI; Salopek TG J Cutan Med Surg; 2015; 19(1):28-34. PubMed ID: 25775660 [TBL] [Abstract][Full Text] [Related]
27. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans. Hisaoka M; Okamoto S; Morimitsu Y; Tsuji S; Hashimoto H Virchows Arch; 1998 Oct; 433(4):323-9. PubMed ID: 9808434 [TBL] [Abstract][Full Text] [Related]
28. Dermatofibrosarcoma Protuberans of Distal Extremities and Acral Sites: A Clinicopathologic Analysis of 27 Cases. Shah KK; McHugh JB; Folpe AL; Patel RM Am J Surg Pathol; 2018 Mar; 42(3):413-419. PubMed ID: 29240584 [TBL] [Abstract][Full Text] [Related]
29. Giant cell fibroblastoma: a report of three cases with histologic and immunohistochemical evidence of a relationship to dermatofibrosarcoma protuberans. Goldblum JR Arch Pathol Lab Med; 1996 Nov; 120(11):1052-5. PubMed ID: 12049108 [TBL] [Abstract][Full Text] [Related]
30. Dermatofibrosarcoma protuberans: a rare entity and review of the literature. Stamatakos M; Fyllos A; Siafogianni A; Ntzeros K; Tasiopoulou G; Rozis M; Kontzoglou K J BUON; 2014; 19(1):34-41. PubMed ID: 24659640 [TBL] [Abstract][Full Text] [Related]
31. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature. Snow SN; Gordon EM; Larson PO; Bagheri MM; Bentz ML; Sable DB Cancer; 2004 Jul; 101(1):28-38. PubMed ID: 15221986 [TBL] [Abstract][Full Text] [Related]
32. Dermatofibrosarcoma protuberans and breast cancer: genetic link or coincidental association? Beech DJ; Long AB; Long WP Am Surg; 2004 Jun; 70(6):543-5. PubMed ID: 15212412 [TBL] [Abstract][Full Text] [Related]
33. PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications. Ha SY; Lee SE; Kwon MJ; Kim YJ; Lee EH; Seo J; Jang KT; Lee J; Choi YL Hum Pathol; 2013 Jul; 44(7):1300-9. PubMed ID: 23347652 [TBL] [Abstract][Full Text] [Related]
34. Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation. Rutkowski P; Klimczak A; Ługowska I; Jagielska B; Wągrodzki M; Dębiec-Rychter M; Pieńkowska-Grela B; Świtaj T Eur J Surg Oncol; 2017 Jun; 43(6):1134-1141. PubMed ID: 28365129 [TBL] [Abstract][Full Text] [Related]
35. Dermatofibrosarcoma protuberans with fibrosarcomatous transformation of the head and neck. Angouridakis N; Kafas P; Jerjes W; Triaridis S; Upile T; Karkavelas G; Nikolaou A Head Neck Oncol; 2011 Feb; 3():5. PubMed ID: 21294902 [TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment. Haycox CL; Odland PB; Olbricht SM; Piepkorn M J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):438-44. PubMed ID: 9308560 [TBL] [Abstract][Full Text] [Related]
37. Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution. Bowne WB; Antonescu CR; Leung DH; Katz SC; Hawkins WG; Woodruff JM; Brennan MF; Lewis JJ Cancer; 2000 Jun; 88(12):2711-20. PubMed ID: 10870053 [TBL] [Abstract][Full Text] [Related]